Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important ...
Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.
Researchers from Charité—Universitätsmedizin Berlin and Stanford University have developed a genome-to-proteome map linking natural genetic variants in yeast to changes in protein abundance and cell ...
When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...
5don MSN
Small differences in cell structures called microtubules determine how well cancer drug performs
A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), ...
Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only ...
Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...
The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...
Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results